{"id":"https://openalex.org/W202224475","doi":null,"title":"\u041f\u0435\u0440\u0432\u044b\u0439 \u043e\u043f\u044b\u0442 \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430 \u0412\u0438\u0437\u043e\u043c\u0438\u0442\u0438\u043d \u0432 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u00ab\u0441\u0443\u0445\u043e\u0433\u043e \u0433\u043b\u0430\u0437\u0430\u00bb","display_name":"\u041f\u0435\u0440\u0432\u044b\u0439 \u043e\u043f\u044b\u0442 \u0438\u0441\u043f\u043e\u043b\u044c\u0437\u043e\u0432\u0430\u043d\u0438\u044f \u043f\u0440\u0435\u043f\u0430\u0440\u0430\u0442\u0430 \u0412\u0438\u0437\u043e\u043c\u0438\u0442\u0438\u043d \u0432 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u00ab\u0441\u0443\u0445\u043e\u0433\u043e \u0433\u043b\u0430\u0437\u0430\u00bb","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W202224475","mag":"202224475"},"language":"ru","primary_location":{"id":"mag:202224475","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/pervyy-opyt-ispolzovaniya-preparata-vizomitin-v-terapii-suhogo-glaza","pdf_url":null,"source":{"id":"https://openalex.org/S4210177312","display_name":"Practical medicine","issn_l":"2072-1757","issn":["2072-1757","2307-3217"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Practical medicine","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090141073","display_name":"\u0415. \u0412. \u042f\u043d\u0438","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0415. \u0412. \u042f\u043d\u0438","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021641404","display_name":"\u041b. \u0410. \u041a\u0430\u0442\u0430\u0440\u0433\u0438\u043d\u0430","orcid":"https://orcid.org/0000-0002-4857-0374","observed_orcids":["https://orcid.org/0000-0002-4857-0374"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041b. \u0410. \u041a\u0430\u0442\u0430\u0440\u0433\u0438\u043d\u0430","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4857-0374","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056069571","display_name":"Natalia B. Chesnokova","orcid":"https://orcid.org/0000-0002-7856-8005","observed_orcids":["https://orcid.org/0000-0002-7856-8005"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041d. \u0411. \u0427\u0435\u0441\u043d\u043e\u043a\u043e\u0432\u0430","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7856-8005","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045816015","display_name":"\u0411\u0435\u0437\u043d\u043e\u0441 \u041e\u043b\u044c\u0433\u0430 \u0412\u0430\u043b\u0435\u0440\u044c\u0435\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0001-7557-4955","observed_orcids":["https://orcid.org/0000-0001-7557-4955","https://orcid.org/0000-0002-1799-5038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u041e. \u0412. \u0411\u0435\u0437\u043d\u043e\u0441","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7557-4955","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063237521","display_name":"\u0410. \u042e. \u0421\u0430\u0432\u0447\u0435\u043d\u043a\u043e","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0410. \u042e. \u0421\u0430\u0432\u0447\u0435\u043d\u043a\u043e","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011475066","display_name":"Vladimir A. Vygodin","orcid":"https://orcid.org/0000-0003-0615-4548","observed_orcids":["https://orcid.org/0000-0003-0615-4548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0412. \u0410. \u0412\u044b\u0433\u043e\u0434\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0615-4548","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028152880","display_name":"\u0415\u043b\u0435\u043d\u0430 \u042e\u0440\u044c\u0435\u0432\u043d\u0430 \u0413\u0443\u0434\u043a\u043e\u0432\u0430","orcid":"https://orcid.org/0009-0009-2313-3483","observed_orcids":["https://orcid.org/0009-0009-2313-3483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0415 \u042e \u0413\u0443\u0434\u043a\u043e\u0432\u0430","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018712457","display_name":"A A Zamiatnin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"\u0410 \u0410 \u0417\u0430\u043c\u044f\u0442\u043d\u0438\u043d","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056961645","display_name":"Maxim V. Skulachev","orcid":"https://orcid.org/0000-0001-6147-8583","observed_orcids":["https://orcid.org/0000-0001-6147-8583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maxim V. Skulachev","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6147-8583","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"1","issue":"59","first_page":"134","last_page":"137"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.7409999966621399},{"id":"https://openalex.org/keywords/mitochondria-targeted-antioxidants","display_name":"mitochondria-targeted antioxidants","score":0.9240000247955322},{"id":"https://openalex.org/keywords/mitochondrial-antioxidants","display_name":"mitochondrial antioxidants","score":0.33899998664855957},{"id":"https://openalex.org/keywords/ophthalmic-drug-therapy","display_name":"ophthalmic drug therapy","score":0.6240000128746033},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.843999981880188},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5578024983406067},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5099934339523315},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47755417227745056},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4477248787879944},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.42768988013267517},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.33476829528808594},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.20266053080558777},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20197948813438416}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:202224475","doi":null,"is_oa":false,"landing_page_url":"https://cyberleninka.ru/article/n/pervyy-opyt-ispolzovaniya-preparata-vizomitin-v-terapii-suhogo-glaza","pdf_url":null,"source":{"id":"https://openalex.org/S4210177312","display_name":"Practical medicine","issn_l":"2072-1757","issn":["2072-1757","2307-3217"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Practical medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1137858161","https://openalex.org/W1981063755","https://openalex.org/W1986853457","https://openalex.org/W1992423211","https://openalex.org/W2135314348","https://openalex.org/W2152273206"],"related_works":["https://openalex.org/W2192161449","https://openalex.org/W7096048758","https://openalex.org/W2926111383","https://openalex.org/W999398730","https://openalex.org/W3122640181","https://openalex.org/W3094479046","https://openalex.org/W7214878412","https://openalex.org/W2912615788","https://openalex.org/W4415533514","https://openalex.org/W2696855049"],"abstract_inverted_index":{"Results":[0,48],"on":[1,8,49],"open":[2],"randomized":[3],"controlled":[4],"comparative":[5],"clinical":[6,56],"trial":[7],"efficacy":[9,43],"and":[10,58],"safety":[11],"of":[12,19,51],"novel":[13],"pharmaceautical":[14,29],"Visomitin":[15,25,40],"in":[16,44],"the":[17,27],"treatment":[18],"'dry":[20],"eye'":[21],"patients":[22],"are":[23,62],"reported.":[24,63],"is":[26],"first":[28],"containing":[30],"mitochondria-targeted":[31],"antioxidant":[32],"as":[33],"an":[34],"active":[35],"substance.":[36],"In":[37],"this":[38],"study":[39],"showed":[41],"high":[42],"dry":[45],"eye":[46],"treatment.":[47],"recovery":[50],"subjective":[52],"condition,":[53],"visual":[54],"acuity,":[55],"parameters":[57],"diagnostic":[59],"tests":[60],"data":[61]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}